PHARMACEUTICAL COMPOSITION CONTAINING ERIODICTYOL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT OF SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING CONTACT DERMATITIS

摘要

The present invention relates to a pharmaceutical composition, a skin external application, a cosmetic composition, and a health functional food including an eriodictyol compound or a pharmaceutically acceptable salt of the same as an active ingredient for preventing or treating contact dermatitis. In particular, the eriodictyol compound or pharmaceutically acceptable salt of the same exhibits an effect in controlling the generation of IgE in contact dermatitis caused by 2,4-dinitrochlorobenzene (DNCB) which is the antigen of delayed type hypersensitivity reaction, and decreases scratching actions, skin functions, and skin thickness for all of the epithelium, corium, and skin increased by DNCB, so that the eriodictyol compound or pharmaceutically acceptable salt of the same can be usefully used as a pharmaceutical composition, a skin external application, a cosmetic composition, and a health functional food.;COPYRIGHT KIPO 2014